PHARMACOGENETICS LTD has a total of 16 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and computer technology are QINGDAO YANGSHEN BIOLOGICAL MEDICINE CO LTD, FISCHER GERALD W and STATENS INST FOR FOLKEHELSE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | China | 3 | |
#4 | Canada | 2 | |
#5 | Australia | 1 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Computer technology | |
#4 | Measurement | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Bioinformatics | |
#5 | Peptides | |
#6 | Microorganisms | |
#7 | Electric digital data processing | |
#8 | Sugars | |
#9 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Xue Hong | 16 |
#2 | Tsang Shui-Ying | 3 |
#3 | He Lin | 3 |
#4 | Ding Xiaofan | 3 |
#5 | Yang Shuang | 3 |
#6 | Liu Wanqing | 2 |
#7 | Feng Guoyin | 2 |
#8 | Wong Jeffrey Tze-Fei | 1 |
#9 | Wang Hongyan | 1 |
#10 | Mei Lingling | 1 |
Publication | Filing date | Title |
---|---|---|
CN110914454A | Genome sequence analysis of human DNA samples contaminated with microorganisms using Whole genome Capture of inter-transposon segment sequences | |
US2018064773A1 | Compositions of medicinal plants for reducing the effects of aging, prevention and treatment of age-related neurodegenerative diseases, and treatment of anxiety and sleep disorders | |
CN106460045A | Use of recurrent copy number variations in constitutional human genome for prediction of predisposition to cancer | |
US2013143746A1 | Method for detecting gene region features based on inter-alu polymerase chain reaction | |
EP1542676A1 | Methods of treating benzodiazepine site (bzd-s) associated syndromes using 2' hydroxyflavonoids | |
US2004198770A1 | Uses for l-tetrahydropalmatine | |
CA2423327A1 | Single nucleotide polymorphisms for the diagnosis and treatment of schizophirenia spectrum disorders | |
CA2385194A1 | Method of diagnosis and treatment for affective disorders |